Results 71 to 80 of about 1,439 (152)

Clinical, organizational, and pharmacoeconomic perspectives of dalbavancin vs standard of care in the infectious disease network

Global & Regional Health Technology Assessment
Introduction: The therapeutic approach to the patient with acute bacterial skin and skin structure infection (ABSSSI) and complicated infections often involves the early transition from intravenous to oral therapy (early switch) or early discharge.
Daniela Segala, Marco Barbieri, Mariachiara Di Nuzzo, Melissa Benazzi, Aurora Bonazza, Letizia Romanini, Brunella Quarta, Kristian Scolz, Anna Marra, Diana Campioni, Rosario Cultrera   +10 more
doaj   +1 more source

Comparative efficacy and safety of antibiotics used to treat acute bacterial skin and skin structure infections: Results of a network meta-analysis.

PLoS ONE, 2017
ObjectiveThis NMA compared the efficacy and safety between IV antibiotics that are used in the current standard of care for managing adult patients (≥18 years of age) with ABSSSI.MethodsComparators were chosen on the basis that both direct and indirect ...
Julian F Guest, Jaime Esteban, Anton G Manganelli, Andrea Novelli, Giuliano Rizzardini, Miquel Serra   +5 more
doaj   +1 more source

Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections

Infection and Drug Resistance, 2016
Travis M Jones,1,2 Steven W Johnson,1,3 V Paul DiMondi,1,4 Dustin T Wilson,1,2 1Department of Pharmacy Practice, College of Pharmacy and Health Sciences, Campbell University, Buies Creek, 2Department of Pharmacy, Duke University Hospital, Durham ...
Jones TM, Johnson SW, DiMondi VP, Wilson DT   +3 more
doaj  

Tedizolid Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection: A Systematic Review and Meta-Analysis

Antibiotics, 2019
This meta-analysis aims to assess the efficacy and safety of tedizolid, compared to linezolid, in the treatment of acute bacterial skin and skin structure infection (ABSSSI). PubMed, Web of Science, EBSCO (Elton B.
Shao-Huan Lan, Wei-Ting Lin, Shen-Peng Chang, Li-Chin Lu, Chien-Ming Chao, Chih-Cheng Lai, Jui-Hsiang Wang   +6 more
doaj   +1 more source

Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections [PDF]

, 2016
In 2013 the US Food and Drug Administration (FDA) issued recommendations and guidance on developing drugs for treatment of skin infection using a new definition of acute bacterial skin and skin-structure infection (ABSSSI).
Concia, E, De Rosa, F. G, Venditti, M, Tumbarello, M, Cristini, F, Concia, E., Petrosillo, N, Petrosillo, N., MENICHETTI, FRANCESCO, De Rosa, F. G., Tumbarello, M., Russo, A, ESPOSITO, Silvano, Russo, A., De Rosa, F.G., Esposito, S, Viscoli, C., CONCIA, Ercole, De Rosa, Francesco Giuseppe, Viale, P, BASSETTI, MATTEO, Menichetti, F., Esposito, S., VISCOLI, CLAUDIO, Tumbarello, Mario, Venditti, M., Menichetti, F, De Rosa, Fg, Viale, P., Cristini, F., Bassetti, M., Viscoli, C   +31 more
core   +1 more source

Treatment of acute bacterial skin and skin structure infection with single-dose dalbavancin in persons who inject drugs

Drugs in Context, 2018
Background: Persons who inject drugs (PWID) are at increased risk of acute bacterial skin and skin structure infections (ABSSSIs), a growing healthcare concern.
Pedro Luis Gonzalez, Urania Rappo , Karthik Akinapelli, Jennifer S McGregor , Sailaja Puttagunta, Michael W Dunne   +5 more
doaj   +1 more source

Clinical Response of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections by Severity Measure Using a Pooled Analysis from Two Phase 3 Double-Blind Trials

, 2017
Tedizolid phosphate is approved for the treatment of acute bacterial skin and skin structure infections (ABSSSI). In a pooled analysis of 1,333 ABSSSI patients from the ESTABLISH clinical trials, treatment with tedizolid or linezolid demonstrated similar
Anita F. Das, Taylor Sandison, Carisa De Anda, Philippe Prokocimer, Edward Fang   +4 more
core   +1 more source

Dalbavancin utilization registry investigating value and effectiveness (DRIVE): Outcomes report on real-world use

Clinical Infection in Practice
Objectives: Dalbavancin has potent activity against Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus, and is approved for treatment of acute bacterial skin and skin structure infections (ABSSSI).
Bruce M. Jones, Kerry O. Cleveland, Pedro L. Gonzalez, Urania Rappo, Todd Riccobene, Rosie D. Lyles   +5 more
doaj   +1 more source

Systematic Review and Meta-Analysis To Estimate Antibacterial Treatment Effect in Acute Bacterial Skin and Skin Structure Infection [PDF]

, 2015
A systematic literature review and meta-analysis were conducted to estimate the antibacterial treatment effect for linezolid and ceftaroline to inform on the design of acute bacterial skin and skin structure infection (ABSSSI) noninferiority trials.
Li, Gang, Mitrani-Gold, Fanny S., Mundy, Linda M.   +2 more
core   +1 more source

Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infections

Infection and Drug Resistance, 2015
Ronald G Hall 2nd, Heidi N Michaels Texas Tech University Health Sciences Center, Dallas, TX, USA Abstract: Tedizolid phosphate is the first once-daily oxazolidinone approved by the United States Food and Drug Administration for the treatment of acute ...
Hall RG 2nd, Michaels HN
doaj